Nano Science and Technology Institute
Nanotech 2012 Vol. 3
Nanotech 2012 Vol. 3
Nanotechnology 2012: Bio Sensors, Instruments, Medical, Environment and Energy (Volume 3)
 
Chapter 5: Environmental Health & Safety
 

Cancer cell targeting of lipid gene vectors by protein corona

Authors:G. Caracciolo, D. Pozzi, A.L. Capriotti, C. Cavaliere, F. Cardarelli, A. Bifone, A. Laganà
Affilation:Sapienza University of Rome, IT
Pages:354 - 357
Keywords:protein corona, cancer cells, gene vectors, lipid, cationic liposomes
Abstract:We investigated the compositional evolution of the protein corona of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) cationic liposomes (CLs) that efficiently deliver DNA in a wide variety of cell lines as a function of increasing human plasma (HP) concentration. We applied liquid chromatography-tandem mass spectrometry to quantitatively identify the proteins adsorbed on DOTAP CLs at 2.5% HP (mimicking the conditions of in vitro experiments) and 50% HP (mimicking the conditions of in vivo experiments) and we observed that, when passing from 2.5% to 50% plasma concentration, fibrinogen is displaced by proteins such as vitronectin and complement C3 proteins. Vitronectin is a major ligand for the vitronectin receptor αVβ3 or αVβ5 integrin, which are overexpressed in some tumor cell lines. Thus, we asked whether the adsorbed protein corona at 50% HP could dictate a selective access to cells expressing vitronectin receptor, that are ανβ3 and ανβ5 integrins. We peformed Confocal Laser Scanning Microscopy and Fluorescence Activated Cell Sorting experiments on metastatic MDA-MB-435 cells that express high level of ανβ3 and ανβ5 integrin and non-metastatic MCF7 that do not express ανβ3 and ανβ5 integrins. We found that DOTAP CLs dressed by protein corona are more efficiently internalized within metastatic MDA-MB-435 cells than naked DOTAP CLs.
ISBN:978-1-4665-6276-9
Pages:818
Hardcopy:$209.95
 
Order:Mail/Fax Form
Up
© 2014 Nano Science and Technology Institute. All Rights Reserved.
Terms of Use | Privacy Policy | Contact Us | Site Map